Koronare Therapie der Mehrgefäßerkrankung: Bypass oder PCI?
Journal Club
First Online:
- 338 Downloads
Therapy of multivessel coronary disease: bypass or PCI?
Notes
Interessenkonflikt
C. Özcelik gibt an, dass kein Interessenkonflikt besteht.
Literatur
- 1.Bangalore S, Guo Y, Samadashvili Z et al (2015) Everolimus-eluting stents or bypass surgery for multivessel coronary disease. N Engl J Med 372:1213–1222PubMedCrossRefGoogle Scholar
- 2.Hannan EL, Racz MJ, McCallister BD et al (1999) A comparison of three-year survival after coronary artery bypass graft surgery and percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 33:63–72PubMedCrossRefGoogle Scholar
- 3.Hannan EL, Racz MJ, Walford G et al (2005) Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 352:2174–2183PubMedCrossRefGoogle Scholar
- 4.Hannan EL, Wu C, Walford G et al (2008) Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med 358:331–341PubMedCrossRefGoogle Scholar
- 5.Mohr FW, Morice MC, Kappetein AP et al (2013) Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 381:629–638PubMedCrossRefGoogle Scholar
Copyright information
© Springer-Verlag Berlin Heidelberg 2015